Teva Respiratory Announces Positive Results From Phase III Trial of BDP HFA ... - PR Newswire (press release)
Posted by admin / Under Metered Dose Inhaler
Teva Respiratory Announces Positive Results From Phase III Trial of BDP HFA ... PR Newswire (press release) ... prior to the US Food and Drug Administration's (FDA) decision to phase out metered dose inhalers (MDIs) that contain chlorofluorocarbons (CFCs), ... |
Published on Friday 30th of July 2010 12:47:57 AM







Share this!